- Home
- HSPO vs GNLX Comparison
HSPO vs GNLX Comparison
Compare HSPO & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSPO
- GNLX
- Stock Information
- Founded
- HSPO 2014
- GNLX 2001
- Country
- HSPO United States
- GNLX United States
- Employees
- HSPO N/A
- GNLX N/A
- Industry
- HSPO Blank Checks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- HSPO Finance
- GNLX Health Care
- Exchange
- HSPO Nasdaq
- GNLX Nasdaq
- Market Cap
- HSPO 92.0M
- GNLX 184.4M
- IPO Year
- HSPO 2022
- GNLX 2023
- Fundamental
- Price
- HSPO $11.73
- GNLX $3.64
- Analyst Decision
- HSPO
- GNLX Strong Buy
- Analyst Count
- HSPO 0
- GNLX 4
- Target Price
- HSPO N/A
- GNLX $18.25
- AVG Volume (30 Days)
- HSPO 1.1K
- GNLX 227.9K
- Earning Date
- HSPO 01-01-0001
- GNLX 03-31-2025
- Dividend Yield
- HSPO N/A
- GNLX N/A
- EPS Growth
- HSPO 2.63
- GNLX N/A
- EPS
- HSPO 0.28
- GNLX N/A
- Revenue
- HSPO N/A
- GNLX $8,000.00
- Revenue This Year
- HSPO N/A
- GNLX N/A
- Revenue Next Year
- HSPO N/A
- GNLX N/A
- P/E Ratio
- HSPO $41.62
- GNLX N/A
- Revenue Growth
- HSPO N/A
- GNLX N/A
- 52 Week Low
- HSPO $10.84
- GNLX $1.60
- 52 Week High
- HSPO $12.41
- GNLX $7.15
- Technical
- Relative Strength Index (RSI)
- HSPO 55.14
- GNLX 42.92
- Support Level
- HSPO $11.61
- GNLX $3.54
- Resistance Level
- HSPO $11.74
- GNLX $4.37
- Average True Range (ATR)
- HSPO 0.01
- GNLX 0.46
- MACD
- HSPO -0.00
- GNLX -0.15
- Stochastic Oscillator
- HSPO 68.24
- GNLX 13.90
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.